Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Medical Sciences|September 8, 2011
Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observationsToshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Plos One|December 30, 2011
Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting systemToshiyuki Sakaeda, Kaori Kadoyama, Yasushi Okuno
Biomedical Chromatography : BMC|March 19, 2016
A validated LC-MS/MS method for the determination of canagliflozin, a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, in a lower volume of rat plasma: application to pharmacokinetic studies in ratsShinji Kobuchi, Kyoka Yano, Yukako Ito, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 15, 2023
Pharmacokinetic evaluation of oxaliplatin combined with S-1 (SOX) chemotherapy in a rat model of colorectal cancer with acute kidney injury: predictive renal biomarkers for dose optimisationTakumi Tanaka, Shinji Kobuchi, Yukako Ito, et al.
European Journal of Drug Metabolism and Pharmacokinetics|February 19, 2021
A Physiologically Based Pharmacokinetic-Pharmacodynamic Model for Capecitabine in Colorectal Cancer Rats: Simulation of Antitumor Efficacy at Various Administration SchedulesShuhei Sakai, Shinji Kobuchi, Yukako Ito, et al.
Bioanalysis|June 4, 2020
A validated LC-MS/MS method for the low-level determination of pemafibrate, a novel SPPARMα, in plasmaShinji Kobuchi, Atsushi Shigemura, Yukako Ito, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2018
Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in ratsShinji Kobuchi, Yukako Ito, Daiki Takamatsu, et al.
Anticancer Research|February 2, 2024
Pharmacokinetic-toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin-induced Peripheral NeuropathyYasuhito Tsukushi, Shinji Kobuchi, Yukako Ito, et al.
Journal of Pharmaceutical Sciences|December 29, 2021
Assessment of Drug-drug Interaction and Optimization in Capecitabine and Irinotecan Combination Regimen using a Physiologically Based Pharmacokinetic ModelShuhei Sakai, Shinji Kobuchi, Yukako Ito, et al.
Biopharmaceutics & Drug Disposition|December 29, 2018
Association between the pharmacokinetics of capecitabine and the plasma dihydrouracil to uracil ratio in rat: A surrogate biomarker for dihydropyrimidine dehydrogenase activityShinji Kobuchi, Mako Akutagawa, Yukako Ito, et al.
Pageof 18